COVID-19 / Coronavirus

UOB puts mental well-being at the heart of its new approach to work post COVID-19

2020-11-13 13:31

SINGAPORE, Nov. 13, 2020 /PRNewswire/ --?UOB today announced that it is giving the majority of its 26,000-strong workforce the choice to work remotely two days a week once COVID-19 restrictions are lifted. Underlying the change is the Bank's desire to ensure the right balance between professional...

Secure World launches "COVID19-Guard", a non-contact, walkthrough-type security solution.

2020-11-13 13:44

* 2020 Pandemic, Korea's Mask mandate is being recognized * The rising cases in Europe calls for adopting a Korean-style guideline and strategies * K-Quarantine has become a role model as COVID-19 spreads in the world * It is recommended to set the technology and strategy standards by benc...

Almost half of working Australians say they need mental health support

2020-11-12 22:34 508

Morneau Shepell's Mental Health Index? for October continues to trend well below the pre-pandemic benchmark with a decline in work productivity MELBOURNE, Nov. 12, 2020 /PRNewswire/ -- Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today ...

Supermicro Scalable Liquid-Cooled Supercomputing Cluster Deployed at Lawrence Livermore National Laboratory for COVID-19 Research

2020-11-12 22:00 1400

SAN JOSE, Calif., Nov. 12, 2020 /PRNewswire/ --?Super Micro Computer, Inc. (Nasdaq: SMCI), a global leader in enterprise computing, storage, networking solutions, and green computing technology, today announced that it has deployed an additional cluster at Lawrence Livermore National Laboratory (...

Positive Impact of Workplace Health & Well-being Programs Highlighted by Cigna Study

2020-11-12 12:11 1496

Report explores the impact of workplace wellness programs;?alongside?expert insights into how to deliver effective initiatives and measure return on investment (ROI) HONG KONG, Nov. 12, 2020 /PRNewswire/ --?Cigna (NYSE:CI) International Markets and Asia Care Group, a leading international resear...

The Sanitation and Hygiene Fund to be launched on 17 November

2020-11-12 08:00 593

GENEVA, Switzerland, Nov. 12, 2020 /PRNewswire/ -- The Sanitation and Hygiene Fund will be launched during an online event next Tuesday. It is seekingUS$2 billion over the coming five years to provide a 21st-century solution to the decades-old crisis on sanitation, hygiene and menstrual health. ...

The Sanitation and Hygiene Fund to be launched on 17 November

2020-11-12 08:00 480

GENEVA, Switzerland, Nov. 12, 2020 /PRNewswire/ -- The Sanitation and Hygiene Fund will be launched during an online event next Tuesday. It is seekingUS$2 billion over the coming five years to provide a 21st-century solution to the decades-old crisis on sanitation, hygiene and menstrual health. ...

I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020

2020-11-11 21:00 2235

SHANGHAI and GAITHERSBURG, Md., Nov. 11, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced new preclinical data fromin vivo and in vitro studies of...

ISSA Global Biorisk Symposium Asean Announced The Symposium for Biorisk Mitigation & Infection Control

2020-11-11 17:36 647

BANGKOK, Nov. 11, 2020 /PRNewswire/ -- Informa Markets in Thailand, the leading exhibition organiser, ISSA, the Worldwide Cleaning Industry Association and GBAC, a Division of ISSA have formed a strategic partnership to help cleaning professionals prepare for, respond to and recover from the nove...

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

2020-11-11 17:30 2007

SINGAPORE, Nov.?11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass? SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

Monograph Published by World Scientific Publishing Proves Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer Effective in Treating COVID-19

2020-11-11 16:07 380

SHANGHAI, Nov. 11, 2020 /PRNewswire/ -- Asclepius Meditec ("the Company") is pleased to announce that Hydrogen Oxygen Generator with Nebulizer – a respiratory medical device developed by the Company for combatting the coronavirus, has been featured in a monograph titled "Hydrogen-Oxygen Inhalati...

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

2020-11-11 16:09 2015

SINGAPORE, Nov.?11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass? SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

Monograph Published by World Scientific Publishing Proves Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer Effective in Treating COVID-19

2020-11-11 15:58 318

SHANGHAI, Nov. 11,?2020 /PRNewswire/ -- Asclepius Meditec ("the Company") is pleased to announce that Hydrogen Oxygen Generator with Nebulizer – a respiratory medical device developed by the Company for combatting the coronavirus, has been featured in a monograph titled "Hydrogen-Oxygen Inhalati...

The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use

2020-11-11 12:51 605

* The emergency use authorization is only granted for limited use during the pandemic, not as a product distribution approval * Data on quality, both non-clinical and clinical, as well as the public health risks are the main considerations JAKARTA, Indonesia, Nov. 11,?2020 /PRNewswire/ -- Eme...

FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform

2020-11-10 22:37 725

World Leader in Fibroblast Technology Advances Intellectual Property Position with their 250th Patent Filed Today HOUSTON, Nov. 10, 2020 /PRNewswire/ --?FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibrob...

iNTERFACEWARE Inc. will be moving to a new office as of November 1st, 2020

2020-11-10 22:00 485

TORONTO, Nov. 10, 2020 /PRNewswire/ -- iNTERFACEWARE Inc., developer of IGUANA?, the market leading health integration engine, announced today it is moving. The Toronto, Canada based company has been developing health integration solutions for over 20 years and is currently serving over 800 cust...

German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container

2020-11-10 19:52 551

BITTERFELD-WOLFEN, Germany, Nov. 10, 2020 /PRNewswire/ -- Vaccine manufacturers, transport and storage providers are facing major challenges in the fight against the coronavirus. MECOTEC Group has announced a complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport + 3. St...

Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit

2020-11-10 16:00 649

Low cost, high-sensitivity diagnostic test for COVID-19 detection IRVINE, Calif., Nov. 10, 2020 /PRNewswire/ --?Zymo Research announced today that it obtained a CE IVD mark for theQuick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of the Counc...

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

2020-11-10 09:00 658

BASEL, Switzerland, Nov. 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. ABasel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal. "The...

I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting

2020-11-09 21:12 2806

SHANGHAI and GAITHERSBURG, Md., Nov. 9, 2020 /PRNewswire/ --?I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced initial results from its U.S. phase 1 clinical trial (NCT...

12345 ... 99